The role develops and executes product strategies, multi-year roadmaps, portfolio plans, commercialization approaches, pricing strategies, and lifecycle plans that support revenue growth, customer adoption, and market competitiveness across biomedical research, drug discovery, disease modeling, toxicology, precision medicine, and cell and gene therapy markets. This remote role is responsible for the commercial success and lifecycle management of ATCC’s advanced cellular models and primary cell product portfolio, including organoids, induced pluripotent stem cells, 3D culture systems, hepatocytes, and PBMCs.